These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10346712)

  • 41. Leading by example. Health plan CEOs helping to reshape the health care policy debate.
    Bethell T
    Healthplan; 2003; 44(3):16-22, 25. PubMed ID: 12808754
    [No Abstract]   [Full Text] [Related]  

  • 42. A bitter pill. Why a Medicare prescription-drug benefit isn't good for our health.
    Birnbaum JH
    Fortune; 2003 Jul; 148(1):36. PubMed ID: 12858794
    [No Abstract]   [Full Text] [Related]  

  • 43. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dueling spending projections. OMB pins $534 billion price tag on Rx benefit.
    Tieman J
    Mod Healthc; 2004 Feb; 34(5):10-1. PubMed ID: 14974299
    [No Abstract]   [Full Text] [Related]  

  • 45. Bush tries to out-liberal the liberals on Medicare.
    Miller M
    Fortune; 2004 Jul; 150(1):60. PubMed ID: 15270461
    [No Abstract]   [Full Text] [Related]  

  • 46. Community pharmacists need information to be effective care team members.
    Exec Solut Healthc Manag; 1998 Oct; 1(8):18-20. PubMed ID: 10186108
    [No Abstract]   [Full Text] [Related]  

  • 47. Solving the American health care cost crises.
    Lanzalotti JA
    J Med Assoc Ga; 1996 Jan; 85(1):15-8. PubMed ID: 8583181
    [No Abstract]   [Full Text] [Related]  

  • 48. Six questions about the new Medicare bill.
    Waller D
    Time; 2003 Dec; 162(23):50-1. PubMed ID: 14712555
    [No Abstract]   [Full Text] [Related]  

  • 49. Sorting out contradictions within managed care.
    Navarro RP
    Med Interface; 1996 Sep; 9(9):85-6. PubMed ID: 10161524
    [No Abstract]   [Full Text] [Related]  

  • 50. The right to health care, the social contract, and health reform in the United States.
    Cassel C
    St Louis Univ Law J; 1994; 39(1):53-64. PubMed ID: 12465630
    [No Abstract]   [Full Text] [Related]  

  • 51. Preparing for what's ahead.
    Pallarito K; Greene J; Lutz S; Kenkel PJ; Morrissey J; Burns J; de Lafuente D; Scott L; Burda D; Japsen B
    Mod Healthc; 1994 Jan; 24(1):31-8, 40-4, 46-8. PubMed ID: 10130658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FTC approves Lilly's PCS purchase.
    Scott L
    Mod Healthc; 1995 Aug; 25(32):30. PubMed ID: 10144477
    [No Abstract]   [Full Text] [Related]  

  • 53. Can health care reform rely on managed care?
    Rice T
    Manag Care Q; 1993; 1(4):50-2. PubMed ID: 10130194
    [No Abstract]   [Full Text] [Related]  

  • 54. Reforming patient assistance programs: perfect world meets real world.
    Weinberg M
    Health Aff (Millwood); 2009; 28(3):839-42. PubMed ID: 19414895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Will administrative savings really pay for health reform?
    Stevens C
    Med Econ; 1993 Oct; 70(20):146-8, 150, 153-4. PubMed ID: 10129289
    [No Abstract]   [Full Text] [Related]  

  • 56. A pragmatic approach to health care reform.
    Tresnowski BR
    Clin Perform Qual Health Care; 1994; 2(1):14-5. PubMed ID: 10135438
    [No Abstract]   [Full Text] [Related]  

  • 57. Universal coverage, drug issues: how do competing health care reform bills compare?
    Gatty B
    Hosp Formul; 1994 Feb; 29(2):158, 157. PubMed ID: 10131878
    [No Abstract]   [Full Text] [Related]  

  • 58. Time to leave the capsule ... if you dare.
    McCarthy R
    Bus Health; 1991 Sep; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HC reform update and drug discounting.
    Lewis WR
    J Healthc Mater Manage; 1994 Mar; 12(3):56-7. PubMed ID: 10134607
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA
    Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.